312 related articles for article (PubMed ID: 33212102)
1. Lactoferrin coated or conjugated nanomaterials as an active targeting approach in nanomedicine.
Agwa MM; Sabra S
Int J Biol Macromol; 2021 Jan; 167():1527-1543. PubMed ID: 33212102
[TBL] [Abstract][Full Text] [Related]
2. Dual-Targeting Lactoferrin-Conjugated Polymerized Magnetic Polydiacetylene-Assembled Nanocarriers with Self-Responsive Fluorescence/Magnetic Resonance Imaging for In Vivo Brain Tumor Therapy.
Fang JH; Chiu TL; Huang WC; Lai YH; Hu SH; Chen YY; Chen SY
Adv Healthc Mater; 2016 Mar; 5(6):688-95. PubMed ID: 26820074
[TBL] [Abstract][Full Text] [Related]
3. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
[TBL] [Abstract][Full Text] [Related]
4. Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand.
Elzoghby AO; Abdelmoneem MA; Hassanin IA; Abd Elwakil MM; Elnaggar MA; Mokhtar S; Fang JY; Elkhodairy KA
Biomaterials; 2020 Dec; 263():120355. PubMed ID: 32932142
[TBL] [Abstract][Full Text] [Related]
5. The proton permeability of self-assembled polymersomes and their neuroprotection by enhancing a neuroprotective peptide across the blood-brain barrier after modification with lactoferrin.
Yu Y; Jiang X; Gong S; Feng L; Zhong Y; Pang Z
Nanoscale; 2014 Mar; 6(6):3250-8. PubMed ID: 24503971
[TBL] [Abstract][Full Text] [Related]
6. Comparative receptor based brain delivery of tramadol-loaded poly(lactic-co-glycolic acid) nanoparticles.
Lalani J; Raichandani Y; Mathur R; Lalan M; Chutani K; Mishra AK; Misra A
J Biomed Nanotechnol; 2012 Dec; 8(6):918-27. PubMed ID: 23030000
[TBL] [Abstract][Full Text] [Related]
7. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
[TBL] [Abstract][Full Text] [Related]
8. Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery.
Chen H; Tang L; Qin Y; Yin Y; Tang J; Tang W; Sun X; Zhang Z; Liu J; He Q
Eur J Pharm Sci; 2010 May; 40(2):94-102. PubMed ID: 20298779
[TBL] [Abstract][Full Text] [Related]
9. Lactoferrin, a unique molecule with diverse therapeutical and nanotechnological applications.
Sabra S; Agwa MM
Int J Biol Macromol; 2020 Dec; 164():1046-1060. PubMed ID: 32707283
[TBL] [Abstract][Full Text] [Related]
10. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
[TBL] [Abstract][Full Text] [Related]
11. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and brain uptake of lactoferrin in rats.
Ji B; Maeda J; Higuchi M; Inoue K; Akita H; Harashima H; Suhara T
Life Sci; 2006 Jan; 78(8):851-5. PubMed ID: 16165165
[TBL] [Abstract][Full Text] [Related]
14. Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.
Shao Z; Shao J; Tan B; Guan S; Liu Z; Zhao Z; He F; Zhao J
Int J Nanomedicine; 2015; 10():1223-33. PubMed ID: 25709444
[TBL] [Abstract][Full Text] [Related]
15. [Targeted nanomedicine in diagnostics and therapy of neurological diseases].
Bertalan F; László B; Attila V
Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015
[TBL] [Abstract][Full Text] [Related]
16. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
Pandey V; Gajbhiye KR; Soni V
Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582
[TBL] [Abstract][Full Text] [Related]
17. Self- assembled lactoferrin-conjugated linoleic acid micelles as an orally active targeted nanoplatform for Alzheimer's disease.
Agwa MM; Abdelmonsif DA; Khattab SN; Sabra S
Int J Biol Macromol; 2020 Nov; 162():246-261. PubMed ID: 32531361
[TBL] [Abstract][Full Text] [Related]
18. Preparation, optimization and cellular uptake study of tanshinone I nanoemulsion modified with lactoferrin for brain drug delivery.
Wu Y; Zhang B; Kebebe D; Guo L; Guo H; Li N; Pi J; Qi D; Guo P; Liu Z
Pharm Dev Technol; 2019 Oct; 24(8):982-991. PubMed ID: 31107131
[TBL] [Abstract][Full Text] [Related]
19. Boosted Memory and Improved Brain Bioavailability of Rivastigmine: Targeting Effort to the Brain Using Covalently Tethered Lower Generation PAMAM Dendrimers with Lactoferrin.
Gothwal A; Nakhate KT; Alexander A; Ajazuddin ; Gupta U
Mol Pharm; 2018 Oct; 15(10):4538-4549. PubMed ID: 30156844
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on Nanodelivery to the Brain: Prerequisites for Successful Brain Treatment.
Hu Y; Hammarlund-Udenaes M
Mol Pharm; 2020 Nov; 17(11):4029-4039. PubMed ID: 33064009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
